CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to test the safety of the use of non-thermal plasma (NTP, an ionized gas) on the tumor bed after the remo ...
Montreal, Quebec, Canada
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Montreal, Quebec, Canada and 71 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Montreal, Canada and 144 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Saint-Jérôme, Quebec, Canada and 318 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Montreal, Quebec, Canada and 28 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Montreal, Quebec, Canada and 39 other locations
in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...
Phase 1, Phase 2
Montreal, Quebec, Canada and 31 other locations
+/HER2-) advanced breast cancer....
Phase 1, Phase 2
Montreal, Quebec, Canada and 32 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Montreal, Quebec, Canada and 166 other locations
treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.HR-positive breast cancer cells have...
Phase 3
Montreal, Quebec, Canada and 205 other locations
Clinical trials
Research sites
Resources
Legal